Healthcare Data Spotlight
According to an independent survey conduct by ITG Market Research of over 500 physicians and hospital professionals:
Sep 23, 2014

-Physicians’ and hospital professionals’ preferred method of participating in market research is via online surveys.
-Physicians and hospital professionals most commonly use Microsoft Internet Explorer (34%), followed by Google Chrome (22%) and Apple Safari (13%).  A total of 19% participated in online research using either an iPhone or iPad.
-The self-reported average amount of time physicians and hospital professionals can spend taking on online survey before the quality of their responses decline is 37.2 minutes.
-When asked to select all devices they use for professional purposes, physicians and hospital professionals most commonly indicate using an iPhone (68%) or iPad (43%).  However, some physicians also mention using an Android-based device (16%) or none at all (8%). (Respondents may have multiple devices.)

More physicians trained on da Vinci From Intuitive Surgical (ISRG) Procedure Tracking Study, October 2013, ITG Market Research
Jan 30, 2014

- Academic hospitals report having 2.1 robots per facility, versus 1.6 for community hospitals, however the largest opportunity in procedure volume growth lies within the community hospitals.
- The key drivers behind the projected growth in procedure volume are facilities’ active marketing use of da Vinci to patients, and an increase in the number of physicians being trained on the da Vinci.

Accountable Care Initiatives Under the Microscope from HOSPITAL EXECUTIVES: Q4 2013 Wave, ITG Market Research

- Approximately 1/3 of US Hospital Executives report that their organization is currently participating in any Accountable Care initiatives; key metrics being evaluated are readmission rates, patient satisfaction, length of stay, and nosocomial infection rates.

View more from Healthcare
Telecom Data Spotlight
Top Selling Phones for 2013
Apr 1, 2014

2013 was another Apple and Samsung year squeezing out most of the other OEM’s offerings in popularity. Adoption of larger screen sizes and lower initial price points drove demand.
View table

Manufacturer Model Type Screen Size
(in inches)
Units Sold
(in 000′s)
% of Total
2013 Sales
Apple iPhone 5 Smartphone iOS 4″ 14,036 11%
Apple iPhone 4s Smartphone iOS 3.5″ 9,980 8%
Samsung Galaxy S4 Smartphone – Android 5″ 9,098 7%
Apple iPhone 5s Smartphone iOS 4″ 8,731 7%
Apple iPhone 4 Smartphone iOS 3.5″ 8,649 7%
Samsung Galaxy S III Smartphone – Android 5″ 8,720 7%
Apple iPhone 5c Smartphone iOS 4″ 5,176 4%
Samsung Gusto 2 Feature Phone 2″ 1,981 2%
LG Motion 4G Smartphone – Android 3.5″ 1,655 1%
HTC One Smartphone – Android 4.7″ 1,380 1%
Grand Total 130,292
Mobile Handset Sales
Apr 1, 2014

With the exception of Apple, Nokia and Blackberry, all other OEM’s were Android Producers. Apple and it’s iPhones led in overall sales followed by Samsung which sells more models in more channels than all the rest of the OEM’s.
View chart

Mobile Handset Sales - December 2014 US Sales by OEM

Source: ITG Monthly Mobile Handset Report – Jan. 2014

Smartphone Operating Systems
Apr 1, 2014

The Android Platform continued its dominant position as the leading smartphone Platform. Following was Apple, then Windows Phone which doubled its share in 2013.
View chart

Smartphone Operating Systems - Trended US Sales Share

Source: ITG Monthly Mobile Handset Report – Jan. 2014

US Share of Handsets Sold
Apr 1, 2014

In 2013 AT&T took a share point away from Verizon to lead in the sales of Mobile Handsets for the year. And T-Mobile did the same with Sprint by gaining two share points while Sprint slipped two points. A share point in the US for 2013 was 1.3M handsets.
View chart

US Share of Handsets Sold - Shift to T-Mobile USA

Source: ITG Monthly Mobile Handset Report – Jan. 2014

View more from Telecom
FDA approves Otezla to treat psoriatic arthritis
Jan 20, 2015

The U.S. Food and Drug Administration today approved Otezla (apremilast) to treat adults with active psoriatic arthritis (PsA).

PsA is a form of arthritis that affects some people with psoriasis. Most people develop psoriasis first and are later diagnosed with PsA. Joint pain, stiffness and swelling are the main signs and symptoms of PsA. Currently approved treatments for PsA include corticosteroids, tumor necrosis factor (TNF) blockers, and an interleukin-12/interleukin-23 inhibitor.

Continue reading >

Syndicated Reports
Dec 6, 2012
Launch of Xgeva Healthcare
Monthly Mobile Device Report Telecom
Launch of PROVENGE Healthcare
Launch of PROLIA Healthcare
Contact us for more information
Join our healthcare panel
Get paid for sharing your opinions and expertise Become a panelist